HomeCASI • NASDAQ
add
CASI Pharmaceuticals Inc
Previous close
$2.89
Day range
$2.58 - $2.90
Year range
$2.07 - $8.19
Market cap
34.98M USD
Avg Volume
55.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 7.79M | -11.82% |
Operating expense | 12.13M | 16.21% |
Net income | -8.40M | -81.12% |
Net profit margin | -107.72 | -105.42% |
Earnings per share | — | — |
EBITDA | -7.15M | -54.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.81M | -41.53% |
Total assets | 63.62M | -14.30% |
Total liabilities | 49.77M | 109.17% |
Total equity | 13.85M | — |
Shares outstanding | 15.29M | — |
Price to book | 3.17 | — |
Return on assets | -35.19% | — |
Return on capital | -66.87% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -8.40M | -81.12% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1991
Headquarters
Website
Employees
176
